AstraZeneca's (AZN) CARES Phase III Clinical Programme Fails to Meet Primary End Point
AstraZeneca PLC (NYSE:AZN) is one of the best stocks to buy now for long term growth. AstraZeneca PLC (NYSE:AZN) reported on May 29 that the global CARES Phase III clinical programme showed that treatment...






